Contact Us

C3 International Inc. was formed to provide leadership in the emerging cannabinoid therapeutics health sector. C3 is the developer of Patent(s)-pending Idrasil™, a breakthrough in pharmaceutical grade for the medical cannabis industry. We welcome all questions from potential patients, health care providers and investors.